Adoption Of Unaudited Standalone Financial Results For The Third Quarter Ended 31St December, 2017
We forward herewith copy of the Un-audited Standalone Financial Results of the Company for the Third Quarter ended December 31, 2017 which were taken on record by the Board of Directors at its meeting held today together with Limited Review Report by Auditors thereon for your information and record. Board Meeting For Conderation Of Unaudited Standalone Financial Results For The Third Quarter Ended 31St December, 2017 Convened On February 12, 2018.
Board Meeting for conderation of Unaudited Standalone Financial Results for the Third Quarter ended 31st December, 2017 convened on February 12, 2018. Trading Window will remain closed for a period of 12 days i.e. Saturday February 3, 2018 to Wednesday February 14, 2018. (Both days inclusive) Change in Corporate Office Address
We wish to inform you that our admin office situated at 101, Shiv Shakti Industrial Estate, Sir M.V. Road, Andheri (E), Mumbai - 400 059 is shifted to Spencer Building, Ground Floor,30, Forjett Street, Tardeo, Mumbai - 400 036, with effect from 1st February, 2018. Shareholding for the Period Ended December 31, 2017
Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended 31St December, 2017
With respect to above, we wish to inform you that the Company has not received any complaints in respect of its Listed Securities i.e. shares during the quarter ended 31st December, 2017. The details are as under: a)No. of complaints as at 1st October, 2017-Nil b)No. of complaints received during the quarter ended 31st December, 2017-Nil c)No. of complaints disposed off during the quarter ended 31st December, 2017-Nil d)No. of Complaints as at 31st December, 2017-Nil Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendra I Gandhi (HUF) Preferential Issue
We wish to inform you that SEBI vide its Letter No. CFD/DIL-1/NS/33156/1/2017 dated 28th December, 2017 granted exemption under Regulation 113 of SEBI(ICDR) Regulations, 2009 from applicability of Regulation 72(2) of SEBI(ICDR) Regulations, 2009 for the proposed issue of warrants on preferential basis to Enai Trading & Investment Private Limited of Promoter group. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendra I Gandhi (HUF) Resignation of Director
we wish to inform you that Mr. Vinod Shanbhag Independent Director has resigned with effect from 7th December 2017. Outcome of Board Meeting
The Board of Directors at their meeting held on 24th November, 2017 has considered un- audited standalone financial results for the second quarter and six months ended 30th September, 2017